AS101-Loaded PLGA–PEG Nanoparticles for Autoimmune Regulation and Chemosensitization
Abstract
The in vivo delivery of therapeutic nanoparticles (NPs) represents a potentially powerful tool that can significantly alter the biological effects of pharmaceutically active compounds. Here, we report on sensitization of tumors to chemotherapy by ammonium trichloro(dioxoethyleneo, o’)tellurate (AS101) encapsulated in NPs, termed AS101-NPs, developed as a composite with the biocompatible and biodegradable copolymer of poly(D,L-lactic-co-glycolic acid)- block-poly(ethylene glycol) (PLGA-b-PEG). AS101 is a potent immunomodulating agent (both in vitro and in vivo) currently undergoing phase II clinical trials for anti-tumor activity and sensitization of tumors to chemotherapy. Approaches that can control the pharmacokinetic parameters to regulate its clearance from the administered drug delivery system and minimize side effects are of prodigious importance. A strategy to synthesize AS101-NPs by nanoprecipitation is presented, along with their physical characterization. The influence of AS101 encapsulation on its properties was evaluated in vivo. The AS101-NPs demonstrated significantly enhanced peritoneal macrophage count compared with AS101 administered in vivo at conventional dosage in mouse models. Moreover, AS101 inhibited B16 melanoma lung metastasis in mice when given intraperitoneally, before or after tumor cell inoculation. A bellshaped dose-response was observed. The frequency of AS101 administration appears to be an important factor for achieving optimal antimetastatic effect.
- Authors:
-
- Bar-Ilan Univ., Ramat-Gan (Israel)
- Publication Date:
- Research Org.:
- Los Alamos National Lab. (LANL), Los Alamos, NM (United States)
- Sponsoring Org.:
- USDOE
- OSTI Identifier:
- 1544701
- Report Number(s):
- LA-UR-19-23090
Journal ID: ISSN 2576-6422
- Grant/Contract Number:
- 89233218CNA000001
- Resource Type:
- Accepted Manuscript
- Journal Name:
- ACS Applied Bio Materials
- Additional Journal Information:
- Journal Volume: 2; Journal Issue: 5; Journal ID: ISSN 2576-6422
- Publisher:
- ACS Publications
- Country of Publication:
- United States
- Language:
- English
- Subject:
- 60 APPLIED LIFE SCIENCES; Material Science
Citation Formats
Mishra, Rahul Kumar, Kumar, Vijay Bhooshan, Monteran, Lea, Sredni, Benjamin, and Gedanken, Aharon. AS101-Loaded PLGA–PEG Nanoparticles for Autoimmune Regulation and Chemosensitization. United States: N. p., 2019.
Web. doi:10.1021/acsabm.9b00200.
Mishra, Rahul Kumar, Kumar, Vijay Bhooshan, Monteran, Lea, Sredni, Benjamin, & Gedanken, Aharon. AS101-Loaded PLGA–PEG Nanoparticles for Autoimmune Regulation and Chemosensitization. United States. https://doi.org/10.1021/acsabm.9b00200
Mishra, Rahul Kumar, Kumar, Vijay Bhooshan, Monteran, Lea, Sredni, Benjamin, and Gedanken, Aharon. Fri .
"AS101-Loaded PLGA–PEG Nanoparticles for Autoimmune Regulation and Chemosensitization". United States. https://doi.org/10.1021/acsabm.9b00200. https://www.osti.gov/servlets/purl/1544701.
@article{osti_1544701,
title = {AS101-Loaded PLGA–PEG Nanoparticles for Autoimmune Regulation and Chemosensitization},
author = {Mishra, Rahul Kumar and Kumar, Vijay Bhooshan and Monteran, Lea and Sredni, Benjamin and Gedanken, Aharon},
abstractNote = {The in vivo delivery of therapeutic nanoparticles (NPs) represents a potentially powerful tool that can significantly alter the biological effects of pharmaceutically active compounds. Here, we report on sensitization of tumors to chemotherapy by ammonium trichloro(dioxoethyleneo, o’)tellurate (AS101) encapsulated in NPs, termed AS101-NPs, developed as a composite with the biocompatible and biodegradable copolymer of poly(D,L-lactic-co-glycolic acid)- block-poly(ethylene glycol) (PLGA-b-PEG). AS101 is a potent immunomodulating agent (both in vitro and in vivo) currently undergoing phase II clinical trials for anti-tumor activity and sensitization of tumors to chemotherapy. Approaches that can control the pharmacokinetic parameters to regulate its clearance from the administered drug delivery system and minimize side effects are of prodigious importance. A strategy to synthesize AS101-NPs by nanoprecipitation is presented, along with their physical characterization. The influence of AS101 encapsulation on its properties was evaluated in vivo. The AS101-NPs demonstrated significantly enhanced peritoneal macrophage count compared with AS101 administered in vivo at conventional dosage in mouse models. Moreover, AS101 inhibited B16 melanoma lung metastasis in mice when given intraperitoneally, before or after tumor cell inoculation. A bellshaped dose-response was observed. The frequency of AS101 administration appears to be an important factor for achieving optimal antimetastatic effect.},
doi = {10.1021/acsabm.9b00200},
journal = {ACS Applied Bio Materials},
number = 5,
volume = 2,
place = {United States},
year = {Fri Apr 12 00:00:00 EDT 2019},
month = {Fri Apr 12 00:00:00 EDT 2019}
}
Works referenced in this record:
Biologic response modifiers: Indications, implications, and insights
journal, May 2017
- Davis, Benjamin P.; Ballas, Zuhair K.
- Journal of Allergy and Clinical Immunology, Vol. 139, Issue 5
Synthesis and Properties of Ammonium Trichloro(dioxyethylene- O , O ′)tellurate (AS-101). A New Immunomodulating Compound
journal, January 1989
- Albeck, M.; Tamari, T.; Sredni, B.
- Synthesis, Vol. 1989, Issue 08
Bone marrow-sparing and prevention of alopecia by AS101 in non-small-cell lung cancer patients treated with carboplatin and etoposide.
journal, September 1995
- Sredni, B.; Albeck, M.; Tichler, T.
- Journal of Clinical Oncology, Vol. 13, Issue 9
Optical trapping and manipulation of single cells using infrared laser beams
journal, December 1987
- Ashkin, A.; Dziedzic, J. M.; Yamane, T.
- Nature, Vol. 330, Issue 6150
Evaluation of anti-cancer and immunomodulatory effects of carnosol in a Balb/c WEHI-164 fibrosarcoma model
journal, July 2014
- Rahnama, Maryam; Mahmoudi, Mahmoud; Zamani Taghizadeh Rabe, Shahrzad
- Journal of Immunotoxicology, Vol. 12, Issue 3
Designing idiosyncratic hmPCL -siRNA nanoformulated capsules for silencing and cancer therapy
journal, April 2016
- Kumar, Vijay Bhooshon; Medhi, Himadri; Yong, Zhang
- Nanomedicine: Nanotechnology, Biology and Medicine, Vol. 12, Issue 3
Encapsulation of Natural Polyphenolic Compounds; a Review
journal, November 2011
- Munin, Aude; Edwards-Lévy, Florence
- Pharmaceutics, Vol. 3, Issue 4
Targeted polymeric therapeutic nanoparticles: design, development and clinical translation
journal, January 2012
- Kamaly, Nazila; Xiao, Zeyu; Valencia, Pedro M.
- Chemical Society Reviews, Vol. 41, Issue 7
Nanomedicine: Developing smarter therapeutic and diagnostic modalities☆
journal, December 2006
- Farokhzad, O.; Langer, R.
- Advanced Drug Delivery Reviews, Vol. 58, Issue 14
Nanoparticle-mediated cellular response is size-dependent
journal, March 2008
- Jiang, Wen; Kim, Betty Y. S.; Rutka, James T.
- Nature Nanotechnology, Vol. 3, Issue 3
Cancer nanotechnology: opportunities and challenges
journal, March 2005
- Ferrari, Mauro
- Nature Reviews Cancer, Vol. 5, Issue 3, p. 161-171
Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles
journal, October 2008
- Dhar, S.; Gu, F. X.; Langer, R.
- Proceedings of the National Academy of Sciences, Vol. 105, Issue 45
Soluble Single-Walled Carbon Nanotubes as Longboat Delivery Systems for Platinum(IV) Anticancer Drug Design
journal, July 2007
- Feazell, Rodney P.; Nakayama-Ratchford, Nozomi; Dai, Hongjie
- Journal of the American Chemical Society, Vol. 129, Issue 27
Platinum(IV)-chlorotoxin (CTX) conjugates for targeting cancer cells
journal, May 2012
- Graf, Nora; Mokhtari, Tara E.; Papayannopoulos, Ioannis A.
- Journal of Inorganic Biochemistry, Vol. 110
Conjugated Platinum(IV)−Peptide Complexes for Targeting Angiogenic Tumor Vasculature
journal, September 2007
- Mukhopadhyay, Sumitra; Barnés, Carmen M.; Haskel, Ariel
- Bioconjugate Chemistry, Vol. 19, Issue 1
Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo
journal, January 2011
- Dhar, Shanta; Kolishetti, Nagesh; Lippard, Stephen J.
- Proceedings of the National Academy of Sciences, Vol. 108, Issue 5
Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy
journal, October 2010
- Kolishetti, N.; Dhar, S.; Valencia, P. M.
- Proceedings of the National Academy of Sciences, Vol. 107, Issue 42
Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile
journal, April 2012
- Hrkach, J.; Von Hoff, D.; Ali, M. M.
- Science Translational Medicine, Vol. 4, Issue 128
Interactions of nanomaterials and biological systems: Implications to personalized nanomedicine
journal, October 2012
- Zhang, Xue-Qing; Xu, Xiaoyang; Bertrand, Nicolas
- Advanced Drug Delivery Reviews, Vol. 64, Issue 13
The Pharmacology of PEGylation: Balancing PD with PK to Generate Novel Therapeutics
journal, October 2008
- Fishburn, C. Simone
- Journal of Pharmaceutical Sciences, Vol. 97, Issue 10
Antibody targeting of liposomes: cell specificity obtained by conjugation of F(ab')2 to vesicle surface
journal, October 1980
- Heath, T.; Fraley, R.; Papahdjopoulos, D.
- Science, Vol. 210, Issue 4469
Self-Assembled Targeted Nanoparticles: Evolution of Technologies and Bench to Bedside Translation
journal, October 2011
- Shi, Jinjun; Xiao, Zeyu; Kamaly, Nazila
- Accounts of Chemical Research, Vol. 44, Issue 10
Nanoparticle Encapsulation of Mitaplatin and the Effect Thereof on In Vivo Properties
journal, May 2013
- Johnstone, Timothy C.; Kulak, Nora; Pridgen, Eric M.
- ACS Nano, Vol. 7, Issue 7
Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo
journal, April 2006
- Farokhzad, O. C.; Cheng, J.; Teply, B. A.
- Proceedings of the National Academy of Sciences, Vol. 103, Issue 16
Formulation of functionalized PLGA–PEG nanoparticles for in vivo targeted drug delivery
journal, February 2007
- Cheng, J.; Teply, B.; Sherifi, I.
- Biomaterials, Vol. 28, Issue 5
Engineered nanomedicine for myeloma and bone microenvironment targeting
journal, June 2014
- Swami, A.; Reagan, M. R.; Basto, P.
- Proceedings of the National Academy of Sciences, Vol. 111, Issue 28
Works referencing / citing this record:
Improving the Li–S battery performance by applying a combined interface engineering approach on the Li 2 S cathode
journal, January 2019
- Hao, Junran; Pan, Yuede; Chen, Weihua
- Journal of Materials Chemistry A, Vol. 7, Issue 48
Strong luminescence and sharp heavy metal ion sensitivity of water-soluble hybrid polysaccharide nanoparticles with Eu3+ and Tb3+ inclusions
journal, May 2019
- Li, Xiao; Wang, Jing; Liu, Jin
- Applied Nanoscience, Vol. 9, Issue 8